Skip to main content

AstraZeneca sells the rights to two hypertension drugs in $400M deal

AstraZeneca will get $250 million when the deal closes and another $150 million by the middle of next year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.